Market News

MSC Income Fund, Inc. (MSIF) Q3 2026 Earnings Call November 6, 2026 11:00 AM ESTCompany ParticipantsZach VaughanDwayne Hyzak - CEO & Chairman of the.....

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Air Products and Chemicals (AP...

CVRx, Inc. (CVRX) Q3 2026 Earnings Call November 5, 2026 4:30 PM ESTCompany ParticipantsKevin Hykes - President, CEO & DirectorJohn Landry - Chief...

Oklo Inc. (OKLO) Q3 2026 Earnings Call November 6, 2026 8:30 AM ESTCompany ParticipantsSam Doane - Senior Director of Investor RelationsJacob Dewitte ...

Global Partners LP Common Units (GLP) Q3 2026 Earnings Call November 6, 2026 10:00 AM ESTCompany ParticipantsKristin Seabrook - Chief Legal Officer &....

Asian equities traded in the US as American depositary receipts were up sharply Friday morning, surg

TIC Solutions, Inc. (TIC) Q3 2026 Earnings Call November 5, 2026 8:30 AM ESTCompany ParticipantsAndrew Shen - Director of Investor RelationsBenjamin H...

Sintx Technologies, Inc. (SINT) Q3 2026 Earnings Call November 5, 2026 4:30 PM ESTCompany ParticipantsKevin Ontiveros - Chief Legal OfficerEric Olson ...

PPL Corporation (PPL) Q3 2026 Earnings Call November 6, 2026 11:00 AM ESTCompany ParticipantsAndy Ludwig - Vice President of Investor RelationsVincent...

Canaccord Genuity analyst Gary Nachman maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $68 to $80.

Enbridge Inc. (ENB:CA) Q3 2026 Earnings Call November 6, 2026 9:00 AM ESTCompany ParticipantsMarlon Samuel - Vice President of Investor Relations &...

Merit Medical's strong product demand, innovation and acquisitions fuel growth, while tariffs, China market pressures and competition remain key chall...

Canaccord Genuity analyst William Plovanic downgrades CVRx (NASDAQ:CVRX) from Buy to Hold and lowers the price target from $5 to $2.

AFRM beats Q1 fiscal 2027 earnings estimates as GMV surges 34% and cardholders more than double, while rising credit loss provisions weigh on gains.

https://ofac.treasury.gov/recent-actions/20261106

Canaccord Genuity analyst David Hynes maintains EverCommerce (NASDAQ:EVCM) with a Buy and lowers the price target from $13 to $9.